Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -61.13% is 45% below its 5-year average of -42.12%, around the middle of its 5-year range (-117.71%–-16.45%).
As of the fiscal period ended Tuesday, June 30, 2026. 31.68% above its 12-month average of -89.47%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -61.13%.
RETURN ON INVESTED CAPITAL (ROIC)
-61.13%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-89.47%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-59.56%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-42.12%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+31.68%
CURRENT VS 3Y AVG
-2.63%
CURRENT VS 5Y AVG
-45.13%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-33.50%
median of 673 covered companies
CURRENT VS SECTOR MEDIAN
-82.46%
vs the sector median at left
Nyxoah S.A.
Market Cap
$143.10M
Return on Invested Capital (ROIC)
-61.13%
TTM Avg
-89.47%
3Y Avg
-59.56%
5Y Avg
-42.12%
Market Cap
$145.88M
Return on Invested Capital (ROIC)
-32.73%
TTM Avg
-84.24%
3Y Avg
-68.85%
5Y Avg
-57.28%
Market Cap
$140.03M
Return on Invested Capital (ROIC)
-7.01%
TTM Avg
-1.96%
3Y Avg
-0.91%
5Y Avg
1.75%
Market Cap
$139.73M
Return on Invested Capital (ROIC)
-10.85%
TTM Avg
-101.00%
3Y Avg
-120.85%
5Y Avg
-96.47%
Market Cap
$139.63M
Return on Invested Capital (ROIC)
-50.04%
TTM Avg
-28.33%
3Y Avg
-324.90%
5Y Avg
-237.35%
Market Cap
$146.58M
Return on Invested Capital (ROIC)
-134.15%
TTM Avg
-47.87%
3Y Avg
-96.96%
5Y Avg
-96.99%
Market Cap
$148.36M
Return on Invested Capital (ROIC)
-223.90%
TTM Avg
-825.42%
3Y Avg
-606.12%
5Y Avg
-416.73%
Market Cap
$147.97M
Return on Invested Capital (ROIC)
-143.97%
TTM Avg
-52.39%
3Y Avg
-55.03%
5Y Avg
-91.26%
Market Cap
$136.88M
Return on Invested Capital (ROIC)
-7.95%
TTM Avg
-23.12%
3Y Avg
-29.64%
5Y Avg
-23.50%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Nyxoah S.A. (NYXH) | $143.10M | -61.13% | -89.47% | -59.56% | -42.12% |
| Immuneering Corporation (IMRX)vs › | $145.88M | -32.73% | -84.24% | -68.85% | -57.28% |
| AirSculpt Technologies, Inc. (AIRS)vs › | $140.03M | -7.01% | -1.96% | -0.91% | 1.75% |
| Fortress Biotech, Inc. (FBIOP)vs › | $139.73M | -10.85% | -101.00% | -120.85% | -96.47% |
| Alpha Cognition Inc (ACOG)vs › | $139.63M | -50.04% | -28.33% | -324.90% | -237.35% |
| Korsana Biosciences, Inc. (KRSA)vs › | $146.58M | -134.15% | -47.87% | -96.96% | -96.99% |
| NervGen Pharma Corp. Common stock (NGEN)vs › | $148.36M | -223.90% | -825.42% | -606.12% | -416.73% |
| LifeMD, Inc. (LFMDP)vs › | $147.97M | -143.97% | -52.39% | -55.03% | -91.26% |
| KORU Medical Systems, Inc. (KRMD)vs › | $136.88M | -7.95% | -23.12% | -29.64% | -23.50% |
| Pyxis Oncology, Inc. (PYXS)vs › | $136.44M | -314.66% | -92.03% | -77.08% | -89.09% |
ROIC
-61.1%
ROE
-120.3%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -61.13% |
| 2026-03-31 | -117.71% |
| 2025-12-31 | -87.94% |
| 2025-09-30 | -108.52% |
| 2025-06-30 | -72.07% |
| 2025-03-31 | -57.98% |
| 2024-12-31 | -44.42% |
| 2024-09-30 | -39.55% |
| 2024-06-30 | -35.96% |
| 2024-03-31 | -46.37% |
| 2023-12-31 | -40.25% |
| 2023-09-30 | -33.99% |
| 2023-06-30 | -28.43% |
| 2023-03-31 | -23.70% |
| 2022-12-31 | -24.22% |
| 2022-09-30 | -22.81% |
| 2022-06-30 | -20.73% |
| 2022-03-31 | -18.97% |
| 2021-12-31 | -16.77% |
| 2021-06-30 | -16.45% |
| 2021-03-31 | -11.75% |
| 2020-12-31 | -9.62% |
| 2020-09-30 | -8.52% |
| 2020-06-30 | -25.12% |
| 2019-12-31 | -75.46% |
